Burchill S A, Lewis I J, Selby P
Candlelighter's Children's Cancer Research Laboratory, St James University Hospital, Leeds, UK.
Br J Cancer. 1999 Feb;79(5-6):971-7. doi: 10.1038/sj.bjc.6690155.
Reverse transcriptase polymerase chain reaction (RT-PCR) is increasingly used to detect small numbers of circulating tumour cells, though the clinical benefit remains controversial. The largest single contributing factor to the controversy of its value is the different approaches to sample processing. The aim of this study was to compare the sensitivity and reproducibility of RT-PCR for the detection of tumour cells after four commonly used different methods of sample processing. Using RT-PCR, one tumour cell spiked in 2 ml of whole blood was detected after analysis of separated mononuclear cell RNA, whole blood total or poly-A+ RNA. No false positives were identified with any method. However, the reproducibility of tumour cell detection was reduced after isolation of the mononuclear cell fraction. Only analysis of poly-A+ RNA had a sensitivity of 100% in all the cell spiking experiments. In patient blood samples, analysis of poly-A+ RNA increased the number of blood samples positive for tyrosine hydroxylase (TH) mRNA compared with those positive after analysis of total RNA. This may reflect high levels of cDNA reducing the efficiency of the PCR. Isolation of poly-A+ RNA increases the sensitivity and reproducibility of tumour cell detection in peripheral blood.
逆转录聚合酶链反应(RT-PCR)越来越多地用于检测少量循环肿瘤细胞,但其临床益处仍存在争议。其价值争议的最大单一因素是样本处理方法的不同。本研究的目的是比较四种常用的不同样本处理方法后RT-PCR检测肿瘤细胞的敏感性和可重复性。使用RT-PCR,在分析分离的单核细胞RNA、全血总RNA或聚腺苷酸加尾RNA(poly-A+RNA)后,检测到2毫升全血中加入的一个肿瘤细胞。任何方法均未发现假阳性。然而,分离单核细胞组分后肿瘤细胞检测的可重复性降低。在所有细胞加样实验中,仅聚腺苷酸加尾RNA分析的敏感性为100%。在患者血样中,与总RNA分析后的阳性血样相比,聚腺苷酸加尾RNA分析增加了酪氨酸羟化酶(TH)mRNA阳性的血样数量。这可能反映了高水平的互补DNA(cDNA)降低了PCR的效率。聚腺苷酸加尾RNA的分离提高了外周血中肿瘤细胞检测的敏感性和可重复性。